gastrointestinal disorders

View All

Pharma News
GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Global Therapeutics and Syros Pharmaceuticals have teamed up to move forward to discover, develop and market novel Sickle cell disease and beta-thalassemia therapies.  Inherited blood disorders affect millions of people worldwide. As per NIH, Sickle cell disease affects around 70,000 to 80,000 Americans, wh...

Find More

takeda
Takeda acquisition on Shire raises its share by 25 percent

Takeda revealed on Wednesday that it is thinking to obtain Shire, which led to rise in its share by 25 percent. It also revealed that there has been no approach made to Shire's board and the proposal is at a "preparatory and exploratory" stage. No information about the investment was revealed by the Japanese drug ma...

Find More

Delveinsight
DelveInsight’s Gastrointestinal based Gene Therapy Reports

Gene Therapy: The “Promise” to cure Gastrointestinal disorders! About Gastrointestinal disorders Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestions, the liver, gallblad...

Find More